AUTL AUTOLUS THERAPEUTICS PLC Business Restructuring 8-K Filing 2024 - Lease Amendment Autolus Therapeutics has amended its lease for the Nucleus manufacturing facility in the UK, with the landlord providing up to £18.5 million for improvements, leading to an increase in annual rent by approximately £1.84 million.Get access to all SEC 8-K filings of the AUTOLUS THERAPEUTICS PLC